Skip to content
Screener

Emergent Biosolutions EBS Total Assets

Total Assets at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$113.17B+11.8%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$41.73B+9.2%
SIGA Technologies logo
SIGA TechnologiesSIGA
$175.74M-25.3%
AMP
Amphastar PharmaceuticalsAMPH
$1.74B+8.0%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$3.78B+10.3%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$229.5M—

Other financials

Income statement

See full
Revenue$234.3M+66.3%
Gross profit$137.2M+85.4%
Operating income-$125.1M-7,919%
Net income-$180.2M-1,402%
EPS (diluted)-$3.49-1,486%

Balance sheet

See full
Cash & equivalents$140.9M-48.0%
Total debt$588.2M-13.0%
Total equity$341.4M-36.3%

Cash flow

See full
Operating cash flow$56.1M-47.3%
CapEx$2.1M-27.6%
Free cash flow$54.0M-47.8%

Valuation

See full
Market cap$248.16M-43.0%
Enterprise value$695.46M-17.3%
P/S0.3×-0.2×

Profitability

See full
Gross margin55.9%+2.4pp
Operating margin15%+10.3pp
Net margin9.6%+5.8pp
FCF margin11.9%—

Returns & leverage

See full
Return on equity13.9%+8.1pp
Debt / equity1.7×+0.5×
Current ratio5.4×-0.2×

Where this comes from

Reported directly by Emergent Biosolutions in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026.

Filed
Aug 5, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001367644-26-000082
Line itemJune 30, 2026December 31, 2025
Property, plant and equipment, net178.0205.4
Intangible assets, net261.8436.5
Other assets11.014.2
Total assets$1,116.8$1,318.6
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable$50.2$55.6
Accrued expenses17.112.2

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Emergent Biosolutions's total assets?
Emergent Biosolutions (EBS) reported total assets of $1.12B in Q2 2026.
How has Emergent Biosolutions's total assets changed year-over-year?
Emergent Biosolutions's total assets decreased by 21.2% year-over-year, from $1.42B to $1.12B.
What is the long-term trend for Emergent Biosolutions's total assets?
Over 5 years (2020 to 2025), Emergent Biosolutions's total assets has grown at a -14.5% compound annual growth rate (CAGR), from $2.88B to $1.32B.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.

Ask your AI about Emergent Biosolutions's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude